The pill version of Novo Nordisk’s (NVO) blockbuster drug Ozempic was found to cut the risk of heart attacks, strokes, and other cardiovascular events in a late-stage clinical trial.
The pill version of Novo Nordisk’s ... The Danish pharma giant announced Monday that the oral form of semaglutide, the active ingredient in Ozempic and Wegovy, was shown to reduce the risk ...